−0.24HKD
−233.41 MHKD
84.65 MHKD
934.83 M
About HUA MEDICINE
Sector
CEO
Li Chen
Headquarters
Shanghai
Website
Employees (FY)
177
Founded
2009
ISIN
KYG4644K1022
FIGI
BBG00LVHG0W8
Hua Medicine Ltd. provides drug discovery and development services. It offers drugs for diabetes and Central Nervous System disorders. Its products include Dorzagliatin HMS552, Dorzagliatin+Metformin, Dorzagliatin+DPPIV, Dorzagliatin+SGLT-2, Dorzagliatin+Insulin, Dorzagliatin+GLP-1 and mGLUR5 NAM. The company was founded by Chen Li on November 10, 2009 and is headquartered in Shanghai, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 2552 is 1.52 HKD — it has increased by 0.66% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange HUA MEDICINE stocks are traded under the ticker 2552.
HUA MEDICINE is going to release the next earnings report on Aug 22, 2024. Keep track of upcoming events with our Earnings Calendar.
2552 stock is 4.67% volatile and has beta coefficient of 0.52. Check out the list of the most volatile stocks — is HUA MEDICINE there?
2552 earnings for the last quarter are −0.11 HKD whereas the estimation was 0.24 HKD which accounts for −147.34% surprise. Estimated earnings for the next quarter are 0.38 HKD. See more details about HUA MEDICINE earnings.
HUA MEDICINE revenue for the last quarter amounts to 20.09 M HKD despite the estimated figure of 575.56 M HKD. In the next quarter revenue is expected to reach 631.09 M HKD.
Yes, you can track HUA MEDICINE financials in yearly and quarterly reports right on TradingView.
2552 stock has fallen by 8.43% compared to the previous week, the month change is a 2.56% fall, over the last year HUA MEDICINE has showed a 56.07% decrease.
2552 net income for the last quarter is −130.87 M HKD, while the quarter before that showed −101.89 M HKD of net income which accounts for −28.44% change. Track more HUA MEDICINE financial stats to get the full picture.
Today HUA MEDICINE has the market capitalization of 1.48 B, it has decreased by 2.07% over the last week.
No, 2552 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 2552 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HUA MEDICINE stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 177.00 employees. See our rating of the largest employees — is HUA MEDICINE on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HUA MEDICINE technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HUA MEDICINE stock shows the sell signal. See more of HUA MEDICINE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HUA MEDICINE EBITDA is −331.95 M HKD, and current EBITDA margin is −393.98%. See more stats in HUA MEDICINE financial statements.